2002 – G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity
Integrated or stand alone Drug Discovery services
(from hit findings to IND), to discover & evaluate the therapies of tomorrow together
Proof of Concept Preclinical Services in Oncology
Since the inception of the company, Oncodesign Services has been pioneering in translational pharmacology to study and treat cancer
Proof of Concept Preclinical Services in Inflammation
Oncodesign Services has a big collection of preclinical inflammatory and autoimmune models, covering diseases of the skin, gut, lungs, kidneys, liver and more
Proof of Concept Preclinical Services in Infectious Diseases
Oncodesign Services has BSL2 and BSL3 facilities and local partnerships allowing infectious disease models to be run
Tackling the microbiome in drug discovery
Oncodesign Services has developed translational skills and experience in this growing field to serve the evolving needs of R&D programs…
News & Our Science
Get up to date with the latest Oncodesign Services developments and activities…
Join us!
More than 230 emplyees are innovating and mobilizing their talents to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs for its customers. Have a look how you could help!
Oncodesign Services, a leading CRO
OncodesignServices’ mission is to contribute to the discovery of innovative therapies that are effective against cancers and serious diseases with no known treatments.